Trintellix, A Novel Antidepressant John Ingram Walker, MD January 5, 2015 Trintellix (vortioxetine) formerly named Brintellix is a multimodal antidepressant recently approved by the FDA for the treatment of major depressive disorder that has a number of pharmacologic effects marked by Read More »